Ulcer News and Research

RSS

Twenty-five million Americans suffer from ulcers. An ulcer is a sore or hole in the lining of the stomach or duodenum (the first part of the small intestine). People of any age can get an ulcer and women are affected just as often as men.

Helicobacter pylori (H. pylori) is a bacterium that lives on the lining of the stomach. Although we used to think that spicy food, acid, and stress were the major causes of ulcers, we now know that nine out of ten ulcers are caused by H. pylori. Medicines that reduce stomach acid may make you feel better, but your ulcer may come back. Here's the good news: Since most ulcers are caused by this bacterial infection, they can be cured with the right antibiotics.

Vitamin-rich berries may help prevent glandular ulcers in horses

Adding sea buckthorn berries to the diet of horses could reduce the incidence of glandular gastric ulcers, report researchers.

24 Oct 2012

Study finds decline in inpatient mortality rate for upper gastrointestinal hemorrhage in the U.S.

The number of patients dying from upper gastrointestinal bleeding has decreased over the past two decades, a result researchers attribute to the advances in medical and endoscopic therapies introduced over the past 20 years, according to a report unveiled today at the American College of Gastroenterology's (ACG) 77th Annual Scientific meeting in Las Vegas.

24 Oct 2012

Derma Sciences to initiate DSC127 Phase 3 program in diabetic foot ulcers

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported that based on a meeting held last week with the U.S. Food and Drug Administration (FDA), the Company plans to begin its Phase 3 program in December 2012 in support of a New Drug Application (NDA) for DSC127 for treatment of diabetic foot ulcers.

23 Oct 2012

Best-practices protocol significantly reduces ventilator-associated pneumonia

An intensive care unit-initiated protocol implementing “best practices” significantly reduces ventilator-associated pneumonia, research shows.

8 Oct 2012

Decline in diabetic foot ulcers in clinical practice

The incidence of foot ulcers developing in diabetes patients is decreasing, particularly in Type 2 diabetes, say researchers.

5 Oct 2012

Direct link between pressure ulcers, patient mortality and increased hospitalization

A new clinical study spearheaded by the dean of UCLA's School of Nursing has found a direct correlation between pressure ulcers - commonly known as bedsores - and patient mortality and increased hospitalization.

3 Oct 2012

Autologous skin grafts heal chronic foot ulcers

Scientists have successfully treated chronic diabetic foot ulcers using skin grafts grown from individual patient cell samples.

13 Sep 2012

Kinetic Concepts launches Skin IQ 1000 MCM to help prevent and treat stage I-IV pressure ulcers

Kinetic Concepts, Inc. (KCI) announced today the U.S. launch of the Skin IQ 1000 Microclimate Manager (MCM) by its Therapeutic Support Systems (TSS) business.

6 Sep 2012

Pressure’s not off for diabetic feet

Custom-made footwear for diabetes patients must offload pressure if it is to be effective at preventing ulceration, Dutch researchers emphasize.

30 Aug 2012

Gene therapy applied to peripheral arterial disease

Hepatocyte growth factor gene therapy could be used to treat patients with severe peripheral arterial disease, suggest results of a phase I clinical trial.

21 Aug 2012

Hemodialysis foot ulcer risk not confined to diabetes

Hemodialysis patients with and without diabetes are at risk for foot ulceration, say UK researchers who believe preventive resources must be directed towards both patient groups.

20 Aug 2012

Hemodialysis foot ulcer risk not confined to diabetes

Hemodialysis patients with and without diabetes are at risk for foot ulceration, say UK researchers who believe preventive resources must be directed toward both patient groups.

16 Aug 2012

Medical devices for diabetic peripheral neuropathy: an interview with Dr. Shai Gozani, CEO of NeuroMetrix

About two years ago NeuroMetrix changed their focus from general purpose devices, used to perform nerve conduction tests, to devices designed to specifically address diabetic peripheral neuropathy or DPN.

6 Aug 2012

Skin cell spray key to venous leg ulcer treatment

A spray consisting of a mixture of keratinocyte and fibroblast skin cells holds promise for treatment of venous leg ulcers, show results from a phase II randomized controlled trial published in The Lancet.

3 Aug 2012

Healthpoint Biotherapeutics announces results from HP802-247 Phase 2b trial on venous leg ulcers

Healthpoint Biotherapeutics today announced that the results for its Phase 2b clinical trial investigating the efficacy of HP802-247 in venous leg ulcers is published on The Lancet, beginning August 3, 2012, with Online First access to the article, followed by print publication in the next issue.

3 Aug 2012

Screening tool could help oral cancer detection

Indian researchers report the development of a novel, simple screening tool with a high degree of accuracy for the detection of oral premalignancies that can be used in a general health setting without the need for much training or clinical experience.

2 Aug 2012

Blood flow in blocked arteries to extremities improved by new angioplasty procedure

Patients with blocked arteries to their extremities, known as peripheral artery disease (PAD) or critical limb ischemia (CLI), may now find relief from lower leg pain and wounds caused by impaired leg artery circulation with the previously unproven therapy, percutaneous transluminal angioplasty (PTA).

24 Jul 2012

AstraZeneca plans to conduct ticagrelor plus clopidogrel clinical trial for PAD

AstraZeneca today announced plans to conduct the EUCLID study, a global clinical trial involving 11,500 patients with peripheral artery disease (PAD), a condition affecting approximately 27 million people in Europe and North America.

17 Jul 2012

Quick-Med Technologies grants Derma Sciences global license to NIMBUS antimicrobial technology

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, and Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announce the signing of an agreement whereby Quick-Med Technologies has granted Derma Sciences an exclusive global license to intellectual property related to the novel NIMBUS antimicrobial technology, which is available in BIOGUARD dressings.

13 Jul 2012

Derma Sciences’ MEDIHONEY HCS dressings receive CE Mark

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces receipt of the CE Mark for the Company's patented MEDIHONEY HCS (hydrogel colloidal sheet) dressings.

10 Jul 2012

Ulcer News and Research

Vitamin-rich berries may help prevent glandular ulcers in horses

Study finds decline in inpatient mortality rate for upper gastrointestinal hemorrhage in the U.S.

Derma Sciences to initiate DSC127 Phase 3 program in diabetic foot ulcers

Best-practices protocol significantly reduces ventilator-associated pneumonia

Decline in diabetic foot ulcers in clinical practice

Direct link between pressure ulcers, patient mortality and increased hospitalization

Autologous skin grafts heal chronic foot ulcers

Kinetic Concepts launches Skin IQ 1000 MCM to help prevent and treat stage I-IV pressure ulcers

Pressure’s not off for diabetic feet

Gene therapy applied to peripheral arterial disease

Hemodialysis foot ulcer risk not confined to diabetes

Hemodialysis foot ulcer risk not confined to diabetes

Medical devices for diabetic peripheral neuropathy: an interview with Dr. Shai Gozani, CEO of NeuroMetrix

Skin cell spray key to venous leg ulcer treatment

Healthpoint Biotherapeutics announces results from HP802-247 Phase 2b trial on venous leg ulcers

Screening tool could help oral cancer detection

Blood flow in blocked arteries to extremities improved by new angioplasty procedure

AstraZeneca plans to conduct ticagrelor plus clopidogrel clinical trial for PAD

Quick-Med Technologies grants Derma Sciences global license to NIMBUS antimicrobial technology

Derma Sciences’ MEDIHONEY HCS dressings receive CE Mark

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News